随着越来越多跨国药企发布2024年财报,全球药企业绩TOP 10榜单也已于近日落定。 “老大哥”强生依然稳坐第一,默沙东K药也保住了“药王”地位。 阿斯利康在去年深陷风波,中国市场业绩却创下新高。 罗氏、艾伯维、百时美施贵宝、赛诺菲旗下多款产品年销售额突破10亿甚至百亿美元。 辉瑞和礼来继续押宝减肥药,诺华则通过收购不断扩充实力…… 强生:招兵买马,稳坐第一 2024年强生身为...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.